Last reviewed · How we verify
Staderm (ibuprofen piconol)
Staderm (generic name: ibuprofen piconol) is a Nonsteroidal Anti-inflammatory Drug drug. It is currently in unknown development.
Staderm works by inhibiting the enzyme cyclooxygenase (COX), which is responsible for producing prostaglandins that cause pain and inflammation.
Staderm, also known as ibuprofen piconol, is a nonsteroidal anti-inflammatory drug (NSAID) in the small molecule modality. It is a derivative of ibuprofen, a widely used medication for pain relief and inflammation. However, specific details about its target, FDA approval status, and commercial status are not available. As an NSAID, Staderm is likely used to treat conditions such as arthritis, menstrual cramps, and other pain-related disorders. Further research is needed to confirm its exact indications and safety profile.
At a glance
| Generic name | ibuprofen piconol |
|---|---|
| Drug class | Nonsteroidal Anti-inflammatory Drug |
| Therapeutic area | Pain |
| Phase | unknown |
Mechanism of action
Imagine your body's pain and inflammation response like a fire. Prostaglandins are like the fuel that keeps the fire burning. Staderm puts out the fire by blocking the production of prostaglandins, which helps to reduce pain and inflammation.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Staderm CI brief — competitive landscape report
- Staderm updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Staderm
What is Staderm?
How does Staderm work?
What is the generic name of Staderm?
What drug class is Staderm in?
What development phase is Staderm in?
Related
- Drug class: All Nonsteroidal Anti-inflammatory Drug drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Pain
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing